Austar Lifesciences Ltd. Financial Overview
Austar Lifesciences Ltd.'s market cap is currently HK$486.95M. The company's EPS TTM is HK$0.052; its P/E ratio is 12.97; Austar Lifesciences Ltd. is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
